Search research articles
Contact Us
Filters
Showing results (431-440 of 477) with videos related to
Page
of 48
Sort By:
JACC. Cardiovascular Interventions
|
August 27, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate
Jochen Wöhrle, Julia Seeger, Shqipdona Lahu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
January 20, 2022
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy
Rayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, et al.
JACC. Cardiovascular Interventions
|
June 18, 2018
Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study
Gennaro Giustino, Björn Redfors, Ajay J Kirtane, et al.
Circulation. Cardiovascular Interventions
|
August 26, 2020
Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention
Hironori Hara, Kuniaki Takahashi, Norihiro Kogame, et al.
The American Journal of Cardiology
|
May 2, 2016
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
Gennaro Giustino, Ajay J Kirtane, Usman Baber, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 14, 2019
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy
Geoffrey A Rubin, Ajay J Kirtane, Shmuel Chen, et al.
JACC. Cardiovascular Interventions
|
October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial
Stephen G Ellis, Michal Tendera, Mark A de Belder, et al.
The American Journal of Cardiology
|
July 30, 2017
Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study)
Björn Redfors, Ori Ben-Yehuda, Sheng-Hsuan Lin, et al.
Circulation
|
July 20, 2017
Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort)
Tom Adriaenssens, Michael Joner, Thea C Godschalk, et al.
International Journal of Cardiology
|
September 5, 2017
Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Gennaro Giustino, Björn Redfors, Roxana Mehran, et al.
Page
of 48
Search research articles
Search
Showing results (431-440 of 477) with videos related to
Sort By:
Page
of 48
JACC. Cardiovascular Interventions
|
August 27, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate
Jochen Wöhrle, Julia Seeger, Shqipdona Lahu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
January 20, 2022
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy
Rayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, et al.
JACC. Cardiovascular Interventions
|
June 18, 2018
Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study
Gennaro Giustino, Björn Redfors, Ajay J Kirtane, et al.
Circulation. Cardiovascular Interventions
|
August 26, 2020
Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention
Hironori Hara, Kuniaki Takahashi, Norihiro Kogame, et al.
The American Journal of Cardiology
|
May 2, 2016
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
Gennaro Giustino, Ajay J Kirtane, Usman Baber, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 14, 2019
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy
Geoffrey A Rubin, Ajay J Kirtane, Shmuel Chen, et al.
JACC. Cardiovascular Interventions
|
October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial
Stephen G Ellis, Michal Tendera, Mark A de Belder, et al.
The American Journal of Cardiology
|
July 30, 2017
Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study)
Björn Redfors, Ori Ben-Yehuda, Sheng-Hsuan Lin, et al.
Circulation
|
July 20, 2017
Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort)
Tom Adriaenssens, Michael Joner, Thea C Godschalk, et al.
International Journal of Cardiology
|
September 5, 2017
Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Gennaro Giustino, Björn Redfors, Roxana Mehran, et al.
Page
of 48